Starten Forschungskooperation

10.12.2012 12:33 Uni Stuttgart und Oncomatrix starten Forschungskooperation Andrea Mayer-Grenu Abteilung Hochschulkommunikation Universität Stuttgart Neuer Krebsmedikamente für die Behandlung metastasierender Tumore Das spanische Biopharmazeutik-Unternehmen Oncomatrix und die Universität Stuttgart haben

By continuing to use the site, you agree to the use of cookies. Continue, scroll or accept. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.